---
title: "OSICAT: a neutral primary result in heart-failure monitoring — Vironix"
description: "Telemonitoring did not significantly improve the primary composite endpoint."
image: "https://www.vironix.ai/_astro/open_graph_vironix.uvCNQF08_27tYOt.webp"
canonical: "https://www.vironix.ai/research/studies/osicat-heart-failure-trial"
source: "https://www.vironix.ai/research/studies/osicat-heart-failure-trial"
---

<!-- Generated from https://www.vironix.ai/research/studies/osicat-heart-failure-trial. Do not edit this file directly. -->

[Home](https://www.vironix.ai/index.md) [Research & Evidence](https://www.vironix.ai/research.md) OSICAT: a neutral primary result in heart-failure monitoring

Study summary · 2020 · Randomized trial

# OSICAT: a neutral primary result in heart-failure monitoring

Telemonitoring did not significantly improve the primary composite endpoint.

Summary by Vironix Health · Source review: November 11, 2026  
[How we select and interpret evidence](https://www.vironix.ai/research/methodology.md)

## Original publication

[Telemonitoring versus standard care in heart failure: a randomised multicentre trial](https://onlinelibrary.wiley.com/doi/full/10.1002/ejhf.1906)

Michel Galinier; François Roubille; Philippe Berdague; Gilles Brierre; Philippe Cantie; Patrick Dary; Jean-Marc Ferradou; Olivier Fondard; Jean Philippe Labarre; Jacques Mansourati; François Picard; Jean-Etienne Ricci; Muriel Salvat; Lamia Tartière; Jean-Bernard Ruidavets; Vanina Bongard; Cécile Delval; Guila Lancman; Hélène Pasche; Juan Fernando Ramirez-Gil; Atul Pathak; OSICAT Investigators

French hospital and cardiology centers; INSERM; Air Liquide Santé International; Princess Grace Hospital, Monaco

European Journal of Heart Failure · Online: May 21, 2020 · Issue: June 2020

[DOI: 10.1002/ejhf.1906](https://doi.org/10.1002/ejhf.1906)[PubMed](https://pubmed.ncbi.nlm.nih.gov/32438483/)[Open-access source](https://onlinelibrary.wiley.com/doi/full/10.1002/ejhf.1906)

Journal version of record. · Full text consulted.

## What was studied

Design

Randomized trial

Population

Adults hospitalized for acute HF within the preceding year

Sample

937 analyzed participants (990 enrolled)

Intervention

Daily weight/symptom monitoring with education

Comparator

Standard care

Follow-up

18 months

Setting

France; 38 centers

## Methods

Open-label multicenter randomized trial.

## Findings

For all-cause death or unplanned hospitalization events, the rate ratio was 0.97 (95% CI 0.77–1.23; P=.80). Adjusted secondary and subgroup findings were more favorable.

## Limitations

The analysis excluded 53 of 990 enrolled patients after randomization; 632 completed 18 months. This modified evaluable population and incomplete follow-up complicate interpretation. Favorable secondary or adherence analyses do not overturn the neutral primary result.

## What this means for care delivery

A credible evidence review should include neutral trials when describing likely program benefits.

## Explore the evidence

[RPM](https://www.vironix.ai/research.md#careModels=rpm)[Heart failure](https://www.vironix.ai/research.md#conditions=heart-failure)

## Guides citing this study

-   [How do RPM and CCM work together in a managed care team?](https://www.vironix.ai/research/guides/care-team-workflows.md)
-   [Does remote patient monitoring reduce heart failure hospitalizations?](https://www.vironix.ai/research/guides/heart-failure-hospitalizations.md)

```json
{
  "@context": "https://schema.org",
  "@type": "Organization",
  "@id": "https://www.vironix.ai/#organization",
  "name": "Vironix Health",
  "alternateName": "Vironix",
  "url": "https://www.vironix.ai",
  "logo": "https://www.vironix.ai/_astro/Vironix_Logo_Primary_300.CFX8xheF.png",
  "description": "Vironix is a digital health platform that enables healthcare providers to provide AI-enabled virtual care services to their patients, including remote patient monitoring, chronic care management, remote therapeutic monitoring, and more.",
  "sameAs": [
    "https://www.linkedin.com/company/vironix-health"
  ]
}
{
  "@context": "https://schema.org",
  "@type": "WebSite",
  "@id": "https://www.vironix.ai/#website",
  "url": "https://www.vironix.ai",
  "name": "Vironix Health",
  "publisher": {
    "@id": "https://www.vironix.ai/#organization"
  },
  "inLanguage": "en-US"
}
{
  "@context": "https://schema.org",
  "@type": "BreadcrumbList",
  "itemListElement": [
    {
      "@type": "ListItem",
      "position": 1,
      "name": "Home",
      "item": "https://www.vironix.ai/"
    },
    {
      "@type": "ListItem",
      "position": 2,
      "name": "Research & Evidence",
      "item": "https://www.vironix.ai/research"
    },
    {
      "@type": "ListItem",
      "position": 3,
      "name": "OSICAT: a neutral primary result in heart-failure monitoring",
      "item": "https://www.vironix.ai/research/studies/osicat-heart-failure-trial.html"
    }
  ]
}
{
  "@context": "https://schema.org",
  "@type": "Article",
  "@id": "https://www.vironix.ai/research/studies/osicat-heart-failure-trial#article",
  "headline": "OSICAT: a neutral primary result in heart-failure monitoring",
  "description": "Telemonitoring did not significantly improve the primary composite endpoint.",
  "url": "https://www.vironix.ai/research/studies/osicat-heart-failure-trial",
  "mainEntityOfPage": "https://www.vironix.ai/research/studies/osicat-heart-failure-trial",
  "inLanguage": "en-US",
  "articleSection": "Research & Evidence",
  "isPartOf": {
    "@id": "https://www.vironix.ai/research"
  },
  "datePublished": "2026-11-16T16:43:59.909Z",
  "dateModified": "2026-11-16T16:43:59.917Z",
  "author": {
    "@type": "Organization",
    "name": "Vironix Health",
    "@id": "https://www.vironix.ai/#organization",
    "url": "https://www.vironix.ai/about"
  },
  "publisher": {
    "@id": "https://www.vironix.ai/#organization"
  },
  "citation": {
    "@type": "ScholarlyArticle",
    "@id": "https://doi.org/10.1002/ejhf.1906",
    "name": "Telemonitoring versus standard care in heart failure: a randomised multicentre trial",
    "author": [
      {
        "@type": "Person",
        "name": "Michel Galinier"
      },
      {
        "@type": "Person",
        "name": "François Roubille"
      },
      {
        "@type": "Person",
        "name": "Philippe Berdague"
      },
      {
        "@type": "Person",
        "name": "Gilles Brierre"
      },
      {
        "@type": "Person",
        "name": "Philippe Cantie"
      },
      {
        "@type": "Person",
        "name": "Patrick Dary"
      },
      {
        "@type": "Person",
        "name": "Jean-Marc Ferradou"
      },
      {
        "@type": "Person",
        "name": "Olivier Fondard"
      },
      {
        "@type": "Person",
        "name": "Jean Philippe Labarre"
      },
      {
        "@type": "Person",
        "name": "Jacques Mansourati"
      },
      {
        "@type": "Person",
        "name": "François Picard"
      },
      {
        "@type": "Person",
        "name": "Jean-Etienne Ricci"
      },
      {
        "@type": "Person",
        "name": "Muriel Salvat"
      },
      {
        "@type": "Person",
        "name": "Lamia Tartière"
      },
      {
        "@type": "Person",
        "name": "Jean-Bernard Ruidavets"
      },
      {
        "@type": "Person",
        "name": "Vanina Bongard"
      },
      {
        "@type": "Person",
        "name": "Cécile Delval"
      },
      {
        "@type": "Person",
        "name": "Guila Lancman"
      },
      {
        "@type": "Person",
        "name": "Hélène Pasche"
      },
      {
        "@type": "Person",
        "name": "Juan Fernando Ramirez-Gil"
      },
      {
        "@type": "Person",
        "name": "Atul Pathak"
      },
      {
        "@type": "Organization",
        "name": "OSICAT Investigators"
      }
    ],
    "datePublished": "2020-05-21",
    "url": "https://onlinelibrary.wiley.com/doi/full/10.1002/ejhf.1906",
    "identifier": "10.1002/ejhf.1906",
    "isPartOf": {
      "@type": "Periodical",
      "name": "European Journal of Heart Failure"
    }
  }
}
```
